Blog

 

■ Clinical predictive factors in diabetic kidney disease progression

Nicholas J Radcliffe, Jas‐mine Seah, Michele Clarke et al

J Diabetes Investig. 2017, vol 8(1): 6–18.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217935/

 

■ Presentation, pathology and prognosis of renal disease in type 2 diabetes

Jasmine Tan, L Jonathan Zwi, John F Collins, Mark R Marshall, Tim Cundy

BMJ Open Diabetes Res Care. 2017; vol 5(1): e000412

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574462/

 

■ The large spectrum of renal disease in diabetic patients

S Bermejo, J Pascual, M J Soler

Clinical Kidney Journal 2017, vol 10 (2): 255-256

https://academic.oup.com/ckj/article/10/2/255/2918137/The-large-spectrum-of-renal-disease-in-diabetic

 

■ Concepts in diabetic nephropathy: from pathophysiology to treatment

M Kinaan, H Yau, S Q Martinez, P Kar

Journal of Renal and Hepatic Disorders 2017, vol 1 (2)

https://jrenhep.com/index.php/jrenhep/article/view/17/36

 

■ Diabetic kidney diseae: challenges, progress, and possibilities

R Z Alicic, M T Rooney, K R Tuttle

CJASN may 2017

http://cjasn.asnjournals.org/content/early/2017/07/12/CJN.11491116.full

 

■ Diabetes, kidney disease, and cardiovascular otucomes in the Jackson Heart Study

M Afkarian, R Katz, N Bansal et al

CJASN 2016, vol 11 (8): 1384-1391

http://cjasn.asnjournals.org/content/early/2016/06/23/CJN.13111215.full

 

■ Urinary podocyte-associated mRNA levels correlate with proximal tubule dysfunction in early diabetic nephropathy of type 2 diabetes mellitus

Ligia Petrica, Sorin Ursoniu, Florica Gadalean et AL

Diabetol Metab Syndr. 2017; 9: 3

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5420400/

 

■ Mediterranean style diet is associated with low risk of new-onset diabetes after renal transplantation

Maryse C J Osté, Eva Corpeleijn, Gerjan J Navis et AL

BMJ Open Diabetes Res Care. 2017; 5(1): e000283

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5253439/

 

■ Relationship between diabetic nephropathy and depression: a cross-sectional analysis using the Diabetes Study from the Center of Tokyo Women´s Medical University (DIACET)

Keiko Takasaki, Tetsuya Babazono, Kaya Ishizawa et al

BMJ Open Diabetes Res Care. 2016; 4(1): e000310

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5179608/

 

■ Comparison of hypertension control in patients with diabetes and hypertension and patients with hypertension without diabetes depending on the stage of chronic kidney disease

A Markowicz, W Grzeszczak

Clinical Diabetology 2017, vol 6 (3): 81-89

https://journals.viamedica.pl/clinical_diabetology/article/view/DK.2017.0014/41699

 

■ End-stage renal disease increases rates of adverse glucose events when treating diabetic ketoacidosis or hyperosmolar hyperglycemic state

C M Schaapveld-Davis, A L Negrete, J Q Hudson et al

Clinical Diabetes 2017, vol 35 (4): 202-220

http://clinical.diabetesjournals.org/content/35/4/202

 

■ Urinary sodium concentration is an independent predictor of all-cause and cardiovascular mortality in a type 2 diabetes cohort population

Pierre-Jean Saulnier, Elise Gand, Stéphanie Ragot et al

SURDIAGENE Study group

J Diabetes Res. 2017; 2017: 532735

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5309403/

 

■ Genome-wide association studies identify genetic loci associated with albuminuria in diabetes

Alexander Teumer, Adrienne Tin, Rossella Sorice, Mathias Gorski et a

Diabetes. 2016 Mar; 65(3): 803–817

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764151/

 

■ Lipid abnormalities in type 2 diabetes mellitus patients with overt nephropathy

Sabitha Palazhy, Vijay Viswanathan

Diabetes Metab J. 2017 Apr; 41(2): 128–134.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5409011/

 

■ Should restrictions be relaxed for metformin use in chronic kidney disease? No, We should never again compromise safety

Kamyar Kalantar-Zadeh, Csaba P. Kovesdy

Diabetes Care. 2016 Jul; 39(7): 1281–1286

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915554/

 

■ Systematic literatures review of DPP-4 inhibitors in patients with type 2 diabetes mellitus and renal impairment

Merlin C. Thomas, Päivi M. Paldánius, Rajeev Ayyagari, Siew Hwa Ong, Per-Henrik Groop

Diabetes Ther. 2016 Sep; 7(3): 439–454.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5014795/

 

■ Role of glycemic control on hospital-related outcomes in patients with diabetes mellitus undergoing renal transplantation

Elizabeth M Lamos, Marniker A Wijesinha, Seba Ramhmdani, Laurence S Magder, Kristi D Silver

Diabetes Metab Syndr Obes. 2017; 10: 13–17

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5221556/

 

■ Effects of glycaemic management on diabetic kidney disease

Richard J MacIsaac, George Jerums, Elif I Ekinci

World J Diabetes. 2017 May 15; 8(5): 172–186

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5437616/

 

■ Impact of creatinine methodology on glomerular filtration rate estimation in diabetes

Marijana Vučić Lovrenčić, Vanja Radišić Biljak et al

World J Diabetes. 2017 May 15; 8(5): 222–229

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5437620/

 

■ Ácido úrico sérico e sua associação com hipertensão, nefropatia precoce e doença renal crônica em pacientes diabéticos tipo 2

Fouad, Mohamed, Fathy, Hoda and Zidan, Ama

1. Bras. Nefrol., Dec 2016, vol.38, no.4, p.403-410

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002016000400403&lng=en&nrm=iso&tlng=pt

 

■ Urinary excretion of kidney Aquaporins as possible diagnostic biomarkers of diabetic nephropathy

Luigi Rossi, Maria Celeste Nicoletti, Monica Carmosino et AL

J Diabetes Res. 2017; 2017: 4360357

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299189/

 

■ The effect of different glycaemic states on renal transplant outcomes

Angela Sheu, Barbara Depczynski, Anthony J. O’Sullivan et al

J Diabetes Res. 2016; 2016: 8735782.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5174175/

 

■ Papel das citocinas inflamatórias na nefropatia diabética

A C V Carvalho, C P Domingueti

Rev Soc Bras Clin Med 2016, vol 14 (3): 177-182

http://docs.bvsalud.org/biblioref/2016/10/2133/177-182.pdf

 

■ Interactions between kidney disease and diabetes: dangerous liaisons

Roberto Pecoits-Filho, Hugo Abensur, Carolina C. R. Betônico et AL

Diabetol Metab Syndr. 2016; 8: 50

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964290/

 

■ Urinary biomarkers in the assessment of early diabetic nephropathy

Cristina Gluhovschi, Gheorghe Gluhovschi, Ligia Petrica et AL

J Diabetes Res. 2016; 2016: 4626125

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927990/

 

■ Oxidative stress in diabetic nephropathy with early chronic kidney disease

Alejandra Guillermina Miranda-Díaz, Leonardo Pazarín-Villaseñor, Francisco Gerardo Yanowsky-Escatell, Jorge Andrade-Sierra

J Diabetes Res. 2016; 2016: 7047238

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971321/

 

■ A systems biology overview on human diabetic nephropathy: from genetic susceptibility to post-transcriptional and post-translational modifications

Francesca Conserva, Loreto Gesualdo, Massimo Papale

J Diabetes Res. 2016; 2016: 7934504

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4698547/

 

■ A new cutoff for abnormal proteinuria in diabetes mellitus patients: relationship to albuminuria

O Erman, A Erman A Vodonos et AL

IMAJ 2016,vol 18: 418-421

https://www.ima.org.il/FilesUpload/IMAJ/0/208/104403.pdf

■ Effect of losartan and spironolactone on triglyceride-rich lipoproteins in diabetic nephropathy

Anand Srivastava, Beverley Adams-Huet, Gloria L Vega, Robert D Toto

J Investig Med. 2016 Aug; 64(6): 1102–1108

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975815/

 

■ Novel tubular biomarkers predict renal progression in type 2 diabetes mellitus: a prospective cohort study

Bancha Satirapoj, Kasemsan Aramsaowapak, Theerasak Tangwonglert, Ouppatham Supasyndh

J Diabetes Res. 2016; 2016: 3102962

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031837/

 

■ Avaliação da função renal em pacientes com diabetes mellitus em um município rural do meio oeste de Santa Catarina

D C Braga, M Panka, S Cabral et al

Arq Catarim Med 2016, vol 45 (3): 84-92

http://www.acm.org.br/acm/seer/index.php/arquivos/article/viewFile/114/125

 

■ Diabetic kidney disease: Is there a non-albuminuric phenotype in type 2 diabetic patients?

Laranjinha, Ivo et al.

Nefrología (Madr.), Oct 2016, vol.36, no.5, p.503-509

http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0211-69952016000600503&lng=es&nrm=iso&tlng=en

 

■ Factores predictivos de nefropatía no diabética en pacientes diabéticos. Utilidad de la biopsia renal.

Bermejo, Sheila et al.

Nefrología (Madr.), Oct 2016, vol.36, no.5, p.535-544

http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0211-69952016000600535&lng=es&nrm=iso

 

■ Diabetic kidney disease: Is there a non-albuminuric phenotype in type 2 diabetic patients?

Laranjinha, Ivo et al.

Nefrología (Madr.), Oct 2016, vol.36, no.5, p.503-509

http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0211-69952016000600503&lng=es&nrm=iso

 

■ Alteraciones glucémicas en los pacientes con enfermedad renal crónica.

De’Marziani, G. et al.

Nefrología (Madr.), Abr 2016, vol.36, no.2, p.133-140

http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0211-69952016000200133&lng=es&nrm=iso

 

■ Diabetic kidney disease: a syndrome rather than a single disease

Giorgina B. Piccoli, Giorgio Grassi, Gianfranca Cabiddu et AL

Rev Diabet Stud. 2015 Spring-Summer; 12(1-2): 87–109

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5397985/

 

■ Diabetic kidney disease – a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)

Mark E. Molitch, Amanda I. Adler, Allan Flyvbjerg et al

Kidney Int. 2015, vol 87(1): 20–30

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4214898/

 

■ Documento de consenso para la detección y manejo de la enfermedad renal crónica

Martínez-Castelao, Alberto et a

Nefrología (Madr.), 2014, vol.34, no.2, p.243-262

http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0211-69952014000200014&lng=es&nrm=iso

 

■ by Dr Paulo Fernando Leite

Cardiologia – Centro Médico Unimed BH

Rua Gonçalves Dias 202

Belo Horizonte/MG/Brasil

CRMMG: 7026

Email: pfleite1873@gmail.com

 

■ Screening for diabetic retinopathy: strategies for improving patient follow-up

J B Skaggs, X Zhang, D J Olson et al

North Carolina Medical Journal 2017, vol 78: 121-123

http://www.ncmedicaljournal.com/content/78/2/121.full

 

■ Non-adherence to eye care in people with diabetes

Ann P Murchison, Lisa Hark, Laura T Pizzi et al

BMJ Open Diabetes Res Care. 2017; 5(1): e000333

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574424/

 

■ Diabetic retinopathy screening ratio is improved when using a digital, nonmydriatic fundus camera onsite in a diabetes outpatient clinic

Pia Roser, Hannes Kalscheuer, Jan B. Groener, Daniel Lehnhoff et al

J Diabetes Res. 2016; 2016: 4101890

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745285/

 

■ An innovative Australian outreach model of diabetic retinopathy screening in remote communities

Nicola M. Glasson, Lisa J. Crossland, Sarah L. Larkins

J Diabetes Res. 2016; 2016: 1267215

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4698887/

 

■ Diabetic retinopathy screening and monitoring of early stage disease in Australian general practice: tackling preventable blindness within a chronic care model

Lisa Crossland, Deborah Askew, Robert Ware, Peter Cranstoun, Paul Mitchell, Andrew Bryett, Claire Jackson

J Diabetes Res. 2016; 2016: 8405395

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4698989/

 

■ Diabetic retinopathy screening using telemedicine tools: pilot study in Hungary

Dóra J. Eszes, Dóra J. Szabó, Greg Russell et al

J Diabetes Res. 2016; 2016: 4529824

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5204085/

 

■ The role of dyslipidemia control in the progression of diabetic retinopathy in patients with type 2 diabetes mellitus

Irini P. Chatziralli

Diabetes Ther. 2017 Apr; 8(2): 209–212

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380502/

 

■ Treatment strategies for chorioretinal vascular diseases: advantages and disabantages of individualized therapy

M W Stewart

EMJ Diabet 2016, vol 4 (1): 91-98

http://emjreviews.com/wp-content/uploads/Treatment-Strategies-for-Chorioretinal-Vascular-Diseases-Advantages-and-Disadvantages-of-Individualised-Therapy.pdf

 

■ Fatores de risco e incidência da retinopatia diabética.

Mendanha, Denise Borges de Andrade et al.

Rev. bras.oftalmol., Dez 2016, vol.75, no.6, p.443-446

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802016000600443&lng=en&nrm=iso

 

■ Noninvasive retinal markers in diabetic retinopathy: advancing frombench towards bedsid

Søren Leer Blindbæk, Thomas Lee Torp, Kristian Lundberg et al

J Diabetes Res. 2017; 2017: 2562759.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406729/

 

■ The evaluation of ocular changes in prediabetic individuals

A Sokolowska-Oracz, P Piatkiewicz

Clinical Diabetology 2017, vol 6 (1): 8-16

https://journals.viamedica.pl/clinical_diabetology/article/view/DK.2017.0003/40758

 

■ Overview of ocular anti-vascular endothelial growth factor therapy in the management of diabetic eye complications

Oluwaranti Akiyode, Christine Tran

Diabetes Spectr. 2016 Feb; 29(1): 44–49

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755448/

 

■ Prevalence of undiagnosed diabetic retinopathy among inpatients with diabetes: the diabetic retinopathy inpatient study (DRIPS)

Jessica J Kovarik, Andrew W Eller, Lauren A Willard et al

BMJ Open Diabetes Res Care. 2016; 4(1): e000164

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4761984/

 

■ Problem-solving therapy for adults with diabetic retinopathy and diabetes-specific distress: a pilot randomized controlled trial

Gwyneth Rees, Fleur O’Hare, Marian Saeed et al

BMJ Open Diabetes Res Care. 2017; 5(1): e000307

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5304260/

 

■ Inpatient screening for albuminuria and retinopathy to p´redict long-term mortality in type 2 diabetic patients: a retrospective cohort study

Ya-Mei Hsieh, Wen-Jane Lee, Wayne H.-H. Sheu et al

Diabetol Metab Syndr. 2017; 9: 29

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5415718/

 

■ Visual acuity, retinal sensitivity, and macular thickness changes in diabetic patients withou diabetic retinopathy after cataract surgery

Spela Stunf Pukl, Nataša Vidović Valentinčič, Mojca Urbančič et al

J Diabetes Res. 2017; 2017: 3459156

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5294376/

 

■ Danish nationwide data reveal a link between diabetes mellitus diabetic retinopathy, and glaucoma

Anna Horwitz, Beáta Éva Petrovski, Christian Torp-Pedersen, Miriam Kolko

J Diabetes Res. 2016; 2016: 2684674

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5107855/

 

■ Lower hemoglobin concentration is associated with retinal ischemia and the severity of diabetic retinopathy in type 2 diabetes

Alicia Traveset, Esther Rubinat, Emilio Ortega et AL

J Diabetes Res. 2016; 2016: 3674946

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855016/

 

■ Bariatric surgery and diabetic retinopathy: a systematic review and meta-analysis of controlled clinical studies

C Merlotti, V Ceriani, A Morabito and A Pontiroli

Obesity Review 2017, vol 18 (3): 309-316

http://onlinelibrary.wiley.com/doi/10.1111/obr.12490/full

 

■ Diabetic retinopathy in Italy: epidemiology data and telemedicine screening programs

Stela Vujosevic, Edoardo Midena

J Diabetes Res. 2016; 2016: 3627465

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5136623/

 

■ The adenosinergic system in diabetic retinopathy

1. Vindeirinho, A. R. Santiago, C. Cavadas, A. F. Ambrósio, P. F. Santos

J Diabetes Res. 2016; 2016: 4270301.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789509/

 

■ Circulating biomarkers of diabetic retinopathy: an overview based on physiopathology

Olga Simó-Servat, Rafael Simó, Cristina Hernández

J Diabetes Res. 2016; 2016: 5263798

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916280/

 

■ Neuroprotection as a therapeutic target for diabetic retinopathy

Cristina Hernández, Massimo Dal Monte, Rafael Simó, Giovanni Casini

J Diabetes Res. 2016; 2016: 9508541

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830713/

 

■ Incretin-based therapy for prevention of diabetic vascular complications

Akira Mima

J Diabetes Res. 2016; 2016: 1379274

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735992/

 

■ Diabetic macular edema pathophysiology: vasogenic versus inflammatory

Pedro Romero-Aroca, Marc Baget-Bernaldiz, Alicia Pareja-Rios et al

J Diabetes Res. 2016; 2016: 2156273

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059543/

 

■ Influence of age at diagnosis and time-dependent risk factors on the development of diabetic retinopathy in patient with type 1 diabetes

Luis Forga, María José Goñi, Berta Ibáñez et AL

J Diabetes Res. 2016; 2016: 9898309

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4861784/

 

■ Evaluation of cytokines in type 1 diabetes patients with and without retinopathy

Cardoso, Jéssica F. et al.

1. Bras. Patol. Med. Lab., Feb 2017, vol.53, no.1, p.31-37

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1676-24442017000100031&lng=pt&nrm=iso&tlng=en

 

■ Influence of the epiretinal membrane on ranibizumab therapy outcomes in patients with diabetic macular edema

Ercalik, Nimet Yesim et al.

Arq. Bras. Oftalmol., Dec 2016, vol.79, no.6, p.373-37

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492016000600373&lng=en&nrm=iso&tlng=en

 

■ Corneal backscatter in insulin-dependent and non-insulin-dependent diabetes mellitus patients: a pilot study

Calvo-Maroto, Ana M et al.

Arq. Bras. Oftalmol., June 2017, vol.80, no.3, p.148-153

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492017000300148&lng=en&nrm=iso

 

■ Comparison between multi-spot laser and conventional laser in treatment of diabetic clinically significant macular edema

Elsawah, Kareem Mohsen et al.

Rev. bras.oftalmol., Aug 2017, vol.76, no.4, p.175-180

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802017000400175&lng=en&nrm=iso&tlng=en

 

■ Fatores de risco associados à intervenção com injeção intravítrea de anti-VEGF em pacientes com edema macular diabético

Faria, Aline Roseane Queiroz de Paiva, Lima Neto, Eufrasio de Andrade and Silva, Cesar Cavalcanti da

Rev. bras.oftalmol., Jun 2017, vol.76, no.3, p.121-127

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802017000300121&lng=en&nrm=iso

 

■ Actualización de la retinopatia diabética para médicos de atención primaria: hacia uma mejora de la medicina telemátic

J E Muñoz de Escalona-Rojas, A Quereda-Castañeda, O García-Garcia

Semergen 2016;42:172-6

http://www.elsevier.es/es-revista-semergen-medicina-familia-40-articulo-actualizacion-retinopatia-diabetica-medicos-atencion-S1138359315002488

 

■ Early diagnosis of diabetic retinopathy in primary care.

Jiménez-Báezez, Maria Valeria et al.

Colomb. Med., Mar 2015, vol.46, no.1, p.14-18

http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S1657-95342015000100004&lng=en&nrm=iso

 

■ by Dr Paulo Fernando Leite

Cardiologia – Centro Médico Unimed BH

Rua Gonçalves Dias 202

Belo Horizonte/MG/Brasil

31 30033306       /   40204020

CRMMG: 7026

Email: pfleite1873@gmail.com